ARCHIVES

National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

Public Forum On NRSA Tuition Policies

April 14, 1995

Letters To the Editor: NCI director Broder responds To Kopans On Mammography

October 8, 1993

Kennedy, Waxman Disagree On Authorization Issue; Legislation For NIH, NCI This Congress Threatened

September 26, 1980

ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer

August 27, 2004

NCI Supercomputer To Be Available To Extramural Scientists

June 8, 1984